Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05541042 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Radiogenomics in Glioblastoma: Correlation Between Multiparametric Imaging Biomarkers and Genetic Biomarkers

StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 27, 2022 (before its estimated November 1, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Start date: Nov 1, 2021 to Dec 1, 2022
    • Trial status: Enrolling by Invitation to Not Yet Recruiting
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to evaluate relationships between multiparametric imaging biomarkers and genetic analysis in glioblastoma patients.
Trial Details
NCT Number NCT05541042
Lead Sponsor Henan Provincial People's Hospital
Conditions
(from sponsor)		 Glioblastoma
Related terms Glioblastoma
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov